Intelliscend Nddr Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 20-12-2024
About Intelliscend Nddr
The Corporate was formerly known as Aeglist Nddr Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 M.
Sunilendu Roy, Shashank Roy, Kalpak Vartak, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2019PTC323470
- Company No.
323470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Intelliscend Nddr?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunilendu Roy  | Additional Director | 20-Nov-2019 | Current |
| Shashank Roy | Director | 01-Apr-2019 | Current |
| Kalpak Vartak | Additional Director | 25-Jan-2020 | Current |
| Manmohan Negi | Additional Director | 25-Jan-2020 | Current |
Financial Performance of Intelliscend Nddr.
Intelliscend Nddr Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Intelliscend Nddr?
In 2020, Intelliscend Nddr had a promoter holding of 5.00% and a public holding of 95.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Reakiro Hempire India Private LimitedActive 3 years 10 monthsSunilendu Roy and Shashank Roy are mutual person
- Intelliscend Pharma Research And Consultancy Private LimitedActive 11 years 2 months
Sunilendu Roy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tjsb Sahakari Bank Limited Creation Date: 04 Oct 2022 | ₹2.00 M | Open |
How Many Employees Work at Intelliscend Nddr?
Unlock and access historical data on people associated with Intelliscend Nddr, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intelliscend Nddr, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intelliscend Nddr's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
